CClinicalTrials.gg
TerminatedNCT03222908Updated Dec 26, 2018

Perioperative Smoking Cessation Interventions

An interventional study of Intervention1: Contract Agreement and Intervention2: Implementation Intentions in Smoking Cessation and Perioperative/Postoperative Complications, sponsored by Duke University. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-12-26.

Sponsored by Duke University · Not applicable, Interventional, and Treatment

Why this study was terminated
Slow enrollment and lack of interest
Phase
Not applicable
Study type
Interventional
Enrollment
19
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

To assess impact of behavioral economic principles of precommitment, implementation intentions, and social contracting on smoking cessation for patients undergoing surgery.

Read the detailed description

Purpose \& Objective: Behavioral interventions in surgical patients are an opportunity to improve outcomes through decreased complications, with measurable economic impact. Smoking cessation is one of the most desirable long-term health behaviors for adults with potential substantial impact on postoperative complications

Study Activity \& Population Group: The investigators propose a precommitment contractual agreement implementing behavioral economic principles at the preoperative appointment for active tobacco users undergoing an operation and assessing for ability to quit smoking with testing on the day of surgery, and the durability of cessation over the postoperative course as measured with urine nicotine testing at follow up appointments. The population of interest is adults who currently smoke tobacco or vaporized nicotine who are scheduled to undergo a major operation. The control group is standard of care; prescriptive advice to quit smoking. The intervention is contract agreement for preoperative cessation.

Data Analysis \& Risk Issues: Following informed consent patients will be randomized to control or intervention groups, baseline urine nicotine tests will be performed in clinic. Urine nicotine testing will be performed on the day of enrollment, the day of their operation, and at their one-month follow up appointments. Thirty-day outcomes will be evaluated by retrospective chart review.

02

Conditions studied

  • Smoking Cessation
  • Perioperative/Postoperative Complications

Keywords

  • Behavior
  • Perioperative/Postoperative Complications
  • contract agreement
  • implementation intentions
  • precommitment
  • smoking cessation
03

In context

Postoperative Complications

1,233 studies on the registry are indexed under Postoperative Complications; 292 are open to participants now.

This study's enrollment of 19 is below the median of 119 across 689 interventional studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.

Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • active tobacco use
  • preoperative appointment for an operation within 6 weeks

Exclusion criteria

Exclusion Criteria:

  • active enrollment in tobacco cessation program
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
19 participants (actual)

Study arms

  • No intervention
    Control: Prescriptive Advice

    Amenable patients will be enrolled into the study, their intervention will be current standard of care smoking cessation counseling by their surgeon, they will undergo 3 urine tests and a chart review for outcomes.

  • Experimental
    Intervention1: Contract Agreement

    Amenable patients will be enrolled into the study, their intervention will be a smoking cessation contract with their surgeon, they will undergo 3 urine tests and a chart review for outcomes.

    Behavioral: Intervention1: Contract Agreement

  • Experimental
    Intervention2: Implementation Intentions

    Amenable patients will be enrolled into the study, their intervention will be a worksheet to fill out with their smoking cessation implementation intentions that will be signed by patient and surgeon, they will undergo 3 urine tests and a chart review for outcomes.

    Behavioral: Intervention2: Implementation Intentions

Interventions

  • BehavioralIntervention1: Contract Agreement

    Smoking Cessation Contract

  • BehavioralIntervention2: Implementation Intentions

    Smoking Cessation Contract with worksheet for implementation intentions

06

What researchers measure

Primary outcomes

  1. Smoking Cessation

    Smoking Cessation on Day of Surgery: quantitative point of care urine cotinine test

    Time frame: day of surgery

  2. Smoking Cessation

    Smoking Cessation on first postoperative follow up appointment: quantitative point of care urine cotinine test

    Time frame: day of first postoperative appointment

Secondary outcomes

  1. Postoperative Complications

    National Surgical Quality Improvement Project postoperative complications: based on patient chart review

    Time frame: 30 days postoperatively

07

Study locations

1 site
  • Duke University Medical Center
    Durham, North Carolina 27710, United States
08

References and documents

Individual participant data

Plan to share: No — no plan to share data

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 26, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03222908
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Jul 19, 2017
Start date
Aug 15, 2017
Primary completion
Jun 20, 2018
Completion
Jul 30, 2018
Last update
Dec 26, 2018

Study contacts

Christopher R Mantyh, MD
principal investigator · DUKE DEPARTMENT OF SURGERY

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion